Sunitinib treatment in patients with advanced renal cell cancer: the Brazilian National Cancer Institute (INCA) experience

The aim of this study was to assess the impact of sunitinib treatment in a non-screened group of patients with metastatic renal cell cancer (mRCC) treated by the Brazilian Unified Health System (SUS) at a single reference institution. Retrospective cohort study, which evaluated patients with mRCC wh...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International Brazilian Journal of Urology 2016-07, Vol.42 (4), p.694-703
Hauptverfasser:	Coelho, Rafael Corrêa, Reinert, Tomás, Campos, Franz, Peixoto, Fábio Affonso, de Andrade, Carlos Augusto, Castro, Thalita, Herchenhorn, Daniel
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Aged, 80 and over Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Brazil Carcinoma, Renal Cell - drug therapy Carcinoma, Renal Cell - secondary Disease-Free Survival Female Government Programs Humans Indoles - adverse effects Indoles - therapeutic use Kidney Neoplasms Kidney Neoplasms - drug therapy Kidney Neoplasms - pathology Lung Neoplasms - secondary Lymphatic Metastasis Male Middle Aged National Health Programs Neoplasm Metastasis Original Pyrroles - adverse effects Pyrroles - therapeutic use Retrospective Studies sunitinib [Supplementary Concept] Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!